UBS Group’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

UBS Group’s Portfolio IMVTW Stock Details IMVTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-245	Closed	-$1K	–	8672
2020 Q1	$1K	Sell	245 -14,755	-98%	-$28.3K	﹤0.01%	7888
2019 Q4	$30K	Buy	+15,000	New	+$30.4K	﹤0.01%	6648

UBS Group's IMVTW Position: Q2 2020 in Review

UBS Group sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 245 shares — an estimated $1K sold.

UBS Group first reported a position in IMVTW in Q4 2019 and held it in 2 quarters. The position peaked at $30K in Q4 2019. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.

UBS Group reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
UBS Group sold 245 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $1K.
UBS Group first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q4 2019 and held it in 2 quarters.
UBS Group's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $30K in Q4 2019.
0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.